Natixis Advisors, L.P. Vericel Corp Transaction History
Natixis Advisors, L.P.
- $51.3 Billion
- Q3 2024
A detailed history of Natixis Advisors, L.P. transactions in Vericel Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 36,338 shares of VCEL stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,338
Previous 37,582
3.31%
Holding current value
$2.14 Million
Previous $1.72 Million
10.96%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding VCEL
# of Institutions
277Shares Held
48.3MCall Options Held
91.8KPut Options Held
23.2K-
Black Rock Inc. New York, NY8.06MShares$475 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$226 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$205 Million0.0% of portfolio
-
State Street Corp Boston, MA2.43MShares$143 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$140 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.78B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...